| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.096 | 0.05 |